Resverlogix Corp wins Technology Pioneer Award

Research Money, December, 2007 by Anonymous

Resverlogix Corp is the only Canadian recipient of the 23 2008 Technology Pioneer Awards handed out by the World Economic Forum. The Calgary-based firm was recognized for its development of new molecules used in the treatment of atherosclerosis. Cardiovascular disease (CVD) is identified as the number one cause of death globally, with more than 18 million dead annually.

Current therapies address only 30% of the risk associated with CVD and Resverlogix is aiming at the 70% of those still at risk. It was chosen for the award among 273 nominees nominated by venture capital and technology companies from around the world....

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement